Havemeyer Place LP Purchases Shares of 29,634 The Cooper Companies, Inc. $COO

Havemeyer Place LP purchased a new stake in The Cooper Companies, Inc. (NASDAQ:COOFree Report) during the 4th quarter, HoldingsChannel.com reports. The fund purchased 29,634 shares of the medical device company’s stock, valued at approximately $2,429,000.

Several other institutional investors have also recently added to or reduced their stakes in the business. Capital World Investors lifted its stake in Cooper Companies by 25.7% in the third quarter. Capital World Investors now owns 10,551,592 shares of the medical device company’s stock valued at $723,417,000 after buying an additional 2,159,233 shares during the period. State Street Corp lifted its stake in Cooper Companies by 1.2% in the second quarter. State Street Corp now owns 8,659,741 shares of the medical device company’s stock valued at $616,227,000 after buying an additional 104,910 shares during the period. Wellington Management Group LLP lifted its stake in Cooper Companies by 332.9% in the third quarter. Wellington Management Group LLP now owns 6,184,992 shares of the medical device company’s stock valued at $424,043,000 after buying an additional 4,756,178 shares during the period. Sustainable Growth Advisers LP lifted its stake in Cooper Companies by 22.1% in the third quarter. Sustainable Growth Advisers LP now owns 4,132,535 shares of the medical device company’s stock valued at $283,327,000 after buying an additional 747,476 shares during the period. Finally, Ameriprise Financial Inc. lifted its stake in Cooper Companies by 98.8% in the second quarter. Ameriprise Financial Inc. now owns 3,388,413 shares of the medical device company’s stock valued at $241,120,000 after buying an additional 1,683,561 shares during the period. 24.39% of the stock is owned by institutional investors and hedge funds.

Wall Street Analyst Weigh In

Several equities analysts have issued reports on the company. Piper Sandler set a $86.00 price target on Cooper Companies and gave the company an “overweight” rating in a research note on Monday, June 1st. Wall Street Zen raised Cooper Companies from a “hold” rating to a “buy” rating in a research note on Saturday, February 28th. JPMorgan Chase & Co. dropped their price target on Cooper Companies from $80.00 to $71.00 and set a “neutral” rating on the stock in a research note on Friday. KeyCorp reaffirmed a “sector weight” rating on shares of Cooper Companies in a research report on Friday. Finally, The Goldman Sachs Group set a $61.00 target price on Cooper Companies in a research report on Wednesday, May 27th. One investment analyst has rated the stock with a Strong Buy rating, eight have assigned a Buy rating, six have assigned a Hold rating and two have issued a Sell rating to the company’s stock. According to MarketBeat.com, the company currently has an average rating of “Hold” and a consensus target price of $82.64.

Check Out Our Latest Stock Report on COO

Cooper Companies News Roundup

Here are the key news stories impacting Cooper Companies this week:

  • Positive Sentiment: Cooper Companies posted better-than-expected Q2 results, with EPS of $1.21 topping estimates of $1.10 and revenue of $1.08 billion beating forecasts, while sales rose 7.9% year over year. CooperCompanies Announces Second Quarter 2026 Results
  • Positive Sentiment: Management said it reached agreements to resolve substantially all claims tied to the prior fertility media recall, reducing a major legal overhang and supporting investor confidence in the company’s outlook. QuiverQuant article
  • Positive Sentiment: Needham reaffirmed a Buy rating on COO and lowered its price target to $86, still implying meaningful upside from current levels. TipRanks analyst update
  • Positive Sentiment: Stifel, Baird, and JPMorgan all cut price targets but kept constructive ratings, suggesting analysts see the report as solid even after valuation resets. Benzinga analyst update
  • Neutral Sentiment: The company guided FY2026 EPS to $4.58-$4.66, slightly around consensus, which helps confirm expectations but does not point to a major near-term surprise. Earnings report transcript
  • Negative Sentiment: JPMorgan lowered its price target on COO from $80 to $71 and kept a Neutral rating, reflecting more cautious expectations despite the stock’s recent strength. JPMorgan price target update

Cooper Companies Price Performance

Shares of NASDAQ:COO opened at $67.34 on Friday. The company has a quick ratio of 0.79, a current ratio of 1.34 and a debt-to-equity ratio of 0.22. The Cooper Companies, Inc. has a twelve month low of $58.89 and a twelve month high of $89.83. The stock’s 50 day moving average is $65.09 and its 200-day moving average is $74.52. The firm has a market capitalization of $13.14 billion, a price-to-earnings ratio of 57.07, a PEG ratio of 1.74 and a beta of 0.87.

Cooper Companies (NASDAQ:COOGet Free Report) last issued its earnings results on Thursday, June 4th. The medical device company reported $1.21 earnings per share for the quarter, topping analysts’ consensus estimates of $1.10 by $0.11. Cooper Companies had a return on equity of 10.85% and a net margin of 5.57%.The company had revenue of $1.08 billion for the quarter, compared to analyst estimates of $1.06 billion. During the same period in the prior year, the firm earned $0.96 earnings per share. Cooper Companies’s revenue for the quarter was up 7.9% on a year-over-year basis. Cooper Companies has set its FY 2026 guidance at 4.580-4.660 EPS. Sell-side analysts forecast that The Cooper Companies, Inc. will post 4.63 EPS for the current fiscal year.

About Cooper Companies

(Free Report)

Cooper Companies, Inc (NASDAQ: COO) is a global medical device company headquartered in San Ramon, California. Founded in 1958, the company has grown through strategic acquisitions and organic development to become a major provider of vision care and women’s health products. Cooper Companies operates through two primary business segments—CooperVision and CooperSurgical—each serving specialized markets within the healthcare industry.

The CooperVision segment develops, manufactures and markets a broad range of soft contact lenses, as well as related accessories.

Read More

Want to see what other hedge funds are holding COO? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for The Cooper Companies, Inc. (NASDAQ:COOFree Report).

Institutional Ownership by Quarter for Cooper Companies (NASDAQ:COO)

Receive News & Ratings for Cooper Companies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cooper Companies and related companies with MarketBeat.com's FREE daily email newsletter.